Shanghai Chest Hospital
Shanghai, Xuhui, 200030, China
NCT Number: NCT06892808
Comparison of Non-Surgical Periodontal Therapy versus Background Periodontal Care in Reducing Atrial Fibrillation Recurrence in Patients with AF and Periodontitis: A Randomized Trial with Two Arms (Background Therapy Group vs. Conventional Non-Surgical Therapy Group).
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
Shanghai, Xuhui, 200030, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Diagnosed with periodontitis (2017 World Workshop classification) and periodontal inflamed surface area (PISA) >500 mm².
Willing and able to provide written informed consent.
Exclusion criteria
Active systemic infection, e.g., sepsis, tuberculosis. Current immunosuppressive therapy, e.g., post-transplant medications, long-term corticosteroids.
Chronic hepatitis B or HIV infection. Chronic systemic antibiotic use (>4 weeks). Pregnancy or lactation. Anticipated survival <12 months.
Under local anesthesia, full-mouth debridement (supragingival and subgingival scaling and root planing, FM-SRP) was performed by an experienced periodontist, initiated within 48 hours post-atrial fibrillation ablation and completed in two sessions within 48 hours. Polishing was performed using a rubber cup with prophylaxis paste. The procedure utilized Gracey curettes and piezoelectric ultrasonic tips combined with a force-controlled system.
Postoperative Care Immediate Care: Local Adjunctive Therapy: 2% minocycline gel was injected into deep periodontal pockets (PD ≥5mm). Antimicrobial Rinse: 0.12% chlorhexidine solution (15 mL, 30-second rinse twice daily) for 14 days.
Follow-Up Intervention At the 6-month follow-up, additional oral debridement was performed in the intervention group if indicated by the presence of bleeding points and/or increased probing pocket depth (PPD).
All study participants received oral hygiene instruction using the modified Bass technique. At baseline, supragingival deposits (dental plaque and calculus) were removed with an ultrasonic scaler or rubber cup with prophylaxis paste. To maintain blinding, simulated subgingival instrumentation sounds were played during the procedure for control group participants.
Time frame: From 3 months post-ablation (end of blanking period) to the 12-month follow-up.
Atrial fibrillation (AF) episodes lasting ≥30 seconds occurring from 3 months post-ablation (end of blanking period) to the 12-month follow-up.
Time frame: During the period from 3 months post-ablation to 12-month follow-up.
AF, atrial flutter (AFL), or atrial tachycardia (AT) episodes lasting ≥30 seconds during the period from 3 months post-ablation to 12-month follow-up.
Time frame: At 12 months.
Antiarrhythmic drug usage at 12 months.
Time frame: At 12 months
Change in Periodontal Inflamed Surface Area (PISA) at 12 months
Time frame: At 12 months.
Probing depth (PD) reduction ≥2 mm in ≥50% of sites.
Time frame: At 12 months.
Bleeding on probing (BOP) rate reduction ≥30%.
Time frame: At 12 months.
Clinical attachment level (CAL) stability (change ≤1 mm).
Xu Liu
Other
Effectiveness of Non-Surgical Periodontal Therapy on Atrial Fibrillation Recurrence After Radiofrequency Ablation in Patients with Atrial Fibrillation and High-Inflammatory Burden Periodontitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06808217
Arrhythmias, Cardiac, Atrial Fibrillation
Vienna, Austria
View Trial DetailsNCT05501873
Arrhythmias, Cardiac, Atrial Fibrillation
Brisbane, Australia
View Trial DetailsNCT06748157
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial DetailsNCT06521463
Arrhythmias, Cardiac, Atrial Fibrillation
Birmingham, Alabama, United States
View Trial Details